SCHEMBL6718346

SCHEMBL6718346

CCCCC(C(=O)O)C(CC)c1ccc(OCCNC(=O)c2ccc(O)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.46
RAB9A P51151 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
LMNA P02545 1/20 0.41
GCGR P47871 4/20 0.41
MMP1 P03956 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6715196 0.83 PPARG (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL6716028 0.77 EPHX2 (0.46) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL6718348 0.74 NPC1 (0.47) NPC1RAB9AMEN1KMT2AMAPK1
SCHEMBL6716004 0.72 PPARG (0.52) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL10099596 0.71 L3MBTL1 (0.61) NPC1RAB9AMEN1KMT2AMAPK1
SCHEMBL27117782 0.71 KDM4E (0.51) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL6715078 0.70 PPARG (0.50) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL6714929 0.70 PPARG (0.52) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL10362492 0.69 RARB (0.67) TSHRLMNATP53
SCHEMBL6715213 0.69 RARB (0.53) NPC1RAB9AMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 NPC1 812/4885RAB9A 3140/4885MEN1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.